Outpace Bio

Discovery Tools (Healthcare) · Seattle, WA · Founded 2020 · Privately Held (backing)

Developer of cell therapies designed to improve the safety and efficacy of gene therapies. Outpace Bio is based in Seattle, WA and was founded in 2020. Its last known valuation is $220 million. It has raised $199 million across 1 recorded round; the latest was a $144 million Series B in Jul 2024.

Last price · $/share
—
Implied valuation
$220.0M
Total raised
$199.0M
Last round
Early Stage VC (Series B)
Jul 2024
How much has Outpace Bio raised?
$199.0Macross 1 recorded rounds · Jul 2024 – Jul 2024

Most recently, Outpace Bio raised $144.0M in its Early Stage VC (Series B) (Jul 2024).

Free account
More of Outpace Bio with a free account
  • ·The complete investor list: 20 names
  • ·Watch Outpace Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Outpace Bio round by round

1 rounds
Jul 2024Early Stage VC (Series B)$144.0M▮
+ 1 more investors · free account

How much has Outpace Bio raised?

Outpace Bio has raised $199 million in total; 1 of its rounds is on record. The largest on record was a $144 million Series B in Jul 2024.

Outpace Bio has filed 1 Form D with the SEC, most recently in Aug 2024 ($56 million sold to 25 investors).

Outpace Bio investors

20 investors are on record for Outpace Bio, including Mana Ventures, Gaingels, RA Capital Management and Abstract Ventures. By type, the record holds 5 venture capital firms and 3 asset managers. The Series B in Jul 2024 drew 15 investors.

For fundraisers
Raising for a company like Outpace Bio?

20 investors have backed Outpace Bio — start your target list with the firms already writing checks in discovery tools (healthcare).

See all 20 investors →

Frequently asked about Outpace Bio

How much has Outpace Bio raised?
Outpace Bio has raised $199.0M in total across 1 recorded funding rounds.
When was Outpace Bio's last funding round?
Outpace Bio's most recent recorded round was Early Stage VC (Series B) in Jul 2024, raising $144.0M.
Outpace Bio Funding Rounds & Investors — $199.0M Raised | Premier Alternatives